rss
Evid Based Nurs 3:123 doi:10.1136/ebn.3.4.123
  • Treatment

Oestrogen plus progestin increased venous thromboembolic disease in postmenopausal women with coronary artery disease


 
 QUESTION: Does oestrogen plus progestin increase the risk of venous thromboembolic events in postmenopausal women with established coronary artery disease (CAD)?

Design

Randomised {allocation concealed}*, blinded (investigators, patients, outcome assessors), placebo controlled trial with mean follow up of 4.1 years (Heart and Estrogen/progestin Replacement Study [HERS]).

Setting

20 clinical centres in the US.

Patients

2763 postmenopausal women <80 years of age (mean age 67 y, 89% white) with established CAD but no previous venous thromboembolism and who had not had a hysterectomy. Exclusion criteria were CAD event ≤6 months or hormone use ≤3 months before entry, venous thromboembolism, breast cancer, endometrial cancer, uncontrolled hypertension, diabetes, or other fatal disease. Follow up was …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article